Shares of Godfrey Phillips India Limited fell 4.87% to ₹2,306.90 on the NSE on May 18, 2026, shedding ₹118 from a previous close of ₹2,424.90, as investors looked beyond the headline numbers of what appeared to be a spectacular set of Q4FY26 and FY26 results and focused on a working capital picture that raises questions about earnings quality even in the absence of any suggestion of wrongdoing.
The surface numbers from Q4FY26 are impressive. Consolidated net profit rose 86.5% year on year to ₹522 crore from ₹280 crore. Revenue on a reported basis rose 84.6% year on year to ₹3,486 crore. EBITDA more than doubled, up 105.4% to ₹552.8 crore. For the standalone quarter, revenue grew 13.6% year on year to ₹1,787.3 crore with EBITDA margins expanding sharply to 30.9% from 17.1% — a 1,380 basis point improvement. For FY26, consolidated net profit stood at ₹1,526 crore versus ₹1,072.31 crore in FY25, and total revenue from operations reached ₹9,121 crore from ₹6,767.49 crore. The board declared a final dividend of ₹33 per equity share — a 1,650% dividend — for FY26.
The market is not selling the reported numbers. It is selling the cash conversion gap and the working capital deterioration that sits behind them.
The cash flow problem
For a company that reported PAT of approximately ₹1,500 crore for FY26, operating cash flow came in at approximately ₹500 crore — a cash conversion ratio of roughly 33%. For a tobacco business — which operates in an excise-paid, high-margin, relatively predictable consumer product category — this is a strikingly weak cash conversion. Tobacco companies typically generate cash flows that track closely to reported profits because the product moves quickly through distribution and payment cycles are short. A PAT-to-CFO gap of ₹1,000 crore in a single year demands an explanation.
Two balance sheet items provide it. Trade receivables jumped 76% from ₹516 crore to ₹907 crore. Inventory increased sharply from ₹1,932 crore to ₹2,188 crore. Together, these represent a working capital build of approximately ₹647 crore — a substantial absorption of cash that would otherwise have shown up as operating cash flow.
What may be driving the working capital build
The most analytically coherent explanation — and the one most consistent with the available data — is a combination of aggressive channel loading and inventory push ahead of the cigarette excise duty restructuring that came into effect in February 2026. When excise duty structures change on cigarettes, manufacturers and distributors have a strong incentive to load up on pre-tax-hike inventory — moving product into the channel before the new duty rates apply. This pull-forward of volumes inflates reported revenue and profit in the periods before the restructuring, while the receivables and inventory build reflects the fact that the channel has taken more stock than it can immediately sell through to consumers.
The reported 84.6% YoY revenue growth for Q4FY26 on a consolidated basis is substantially inflated by this tax restructuring effect — underlying net revenue growth, stripping out the pre-restructuring loading effect, is likely materially lower. Cigarette volume growth of approximately 20% is genuine and reflects real distribution expansion, Marlboro scaling, and market share gains. But the optical revenue growth rate of 84.6% does not reflect 84.6% underlying demand growth.
Q4 margins were additionally helped by inventory accounting benefits and operating leverage — further complicating the underlying margin picture for FY27 when these tailwinds will not repeat.
What FY27 will reveal
The critical monitoring variables going into FY27 are debtor days — whether the ₹907 crore in receivables is collected or continues to grow — inventory days — whether the ₹2,188 crore inventory normalises as channel stocks are worked down — and CFO/PAT conversion ratio — whether cash flow recovers toward the 80-90% of PAT that a tobacco business should structurally generate.
If receivables stabilise and cash conversion normalises — indicating that the FY26 working capital build was a one-time pre-restructuring loading event rather than a structural deterioration — Godfrey Phillips at ₹2,306.90 and a P/E of 25.84x on trailing earnings becomes a compelling valuation. Genuine volume growth of 20%, distribution expansion, and Marlboro scaling provide a strong operational foundation. But if debtor days continue to expand and distributor destocking creates volume weakness in Q1 and Q2FY27, the FY26 earnings will have borrowed from FY27 — and the market will need to reassess the earnings base accordingly.
The May 18 selloff is not a verdict on Godfrey Phillips’ business quality. It is the market pricing in the uncertainty of which of these two scenarios plays out.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
Google Discover headline: profit jumped 86% but the stock fell 5% — ₹1,500 crore profit and only ₹500 crore cash tells a different story
SEO meta title: Godfrey Phillips Q4FY26: , shares fall 4.87% on May 18 on weak cash conversion and receivables spike
Next one ready.